Clinical Trials Sponsored by Centro per la Lotta contro l'Infarto - Fondazione Onlus

Total 17 results

Centro per la Lotta Contro l'Infarto - Fondazione...

Recruiting

Interventional Strategy for Non-culprit Lesions With Major Vulnerability Criteria at OCT in Patients With ACS (INTERCLIMA)

Coronary Artery Disease | Coronary Disease | Ischemic Heart Disease

Italy
San Giovanni Addolorata Hospital
Centro per la Lotta Contro l'Infarto - Fondazione Onlus

Unknown

Relationship Between OCT Coronary Plaque Morphology and Clinical Outcome (CLIMA)

Coronary Artery Disease

Spain, Italy, Poland
University of Bologna
University of Cambridge; Centro per la Lotta Contro l'Infarto - Fondazione...

Recruiting

Synergy Between morpHOlogical and inflammatoRy Evaluation in Predicting Long-term Coronary Plaque Progression (SHORE)

Coronary Artery Disease | Inflammation | Atherosclerosis | Acute Coronary Syndrome

Italy
Fondazione Italiana Linfomi ONLUS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Completed

A Multi-centre Study of MBVD in Elderly and/or Cardiopathic Patients Affected by Hodgkin's Lymphoma (HL) (HD0803)

Hodgkin Lymphoma

Italy
Fondazione Italiana Linfomi ONLUS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Completed

Brief Chemoimmunotherapy With R+B+M Followed by R in Elderly Patients Advanced Stage Untreated Follicular Lymphoma (FLE09)

Follicular Lymphoma

Italy
Fondazione Italiana Linfomi ONLUS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Completed

Salvage Treatment With Lenalidomide and Dexamethaosne (LEN-DEX) in Patients With Relapsed/Refractory Mantle Cell Lymphoma (MCL)

MANTLE CELL LYMPHOMA

Italy
Fondazione Italiana Linfomi ONLUS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Completed

High-dose Chemotherapy and Stem Cell Transplantation, in Patients PET-2 Positive, After 2 Courses of ABVD and Comparison of RT Versus no RT in PET-2 Negative Patients (HD0801)

Hodgkin's Lymphoma

Italy
Fondazione Italiana Linfomi ONLUS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Unknown

Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma (REAL07)

Follicular Lymphoma | Non Hodgkin Lymphoma

Italy
Fondazione Italiana Linfomi ONLUS
Centro di Riferimento per l'Epidemiologia e la Prev. Oncologica Piemonte

Unknown

Dose Dense Chemotherapy + Rituximab +/-Intensified High Dose Chemoimmunotherapy With Support of Peripheral Autologous Stem Cell in Diffuse Large B-Cell Lymphoma (DLCL04)

Diffuse Large B-Cell Lymphoma | IPI≥2

Italy
Network Italiano Cure di Supporto in Oncologia
Azienda Ospedaliera di Perugia; Associazione Umbra per la lotta Contro il Cancro and other collaborators

Unknown

American Ginseng for the Prevention of Moderate-severe Fatigue in Breast Cancer Patients

Breast Cancer Female | Cancer Related Fatigue

Italy
Fondazione Italiana Linfomi ONLUS
Janssen Pharmaceutica; Janssen-Cilag Ltd.; Centro di Riferimento per l'Epidemiologia...

Completed

Phase II Randomized Study With R-DHAP +/- Bortezomib as Induction Therapy in Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL) Patients Eligible to Transplantation. BR-DHAP Versus R-DHAP. (FIL_VERAL12)

Diffuse Large B-cell Lymphoma Recurrent | Diffuse Large B-cell Lymphoma Refractory

Italy
Associazione Angela Serra per la ricerca sul cancro
Fondazione Italiana Linfomi ONLUS; The International Non-Hodgkin Lymphoma Prognostic...

Completed

Study of Prognosis of Follicular Lymphoma Through a Prospective Collection of Data (F2-study)

Lymphoma, Follicular

United States, Spain, Italy, Switzerland, United Kingdom, Argentina, Czechia, France
Associazione Angela Serra per la ricerca sul cancro
Fondazione Italiana Linfomi ONLUS; INTERNATIONAL T-CELL NON-HODGKIN'S LYMPHOMA...

Completed

T-Cell Project: Prospective Collection of Data in Patients With Peripheral T-Cell Lymphoma

Lymphoma, T-Cell, Peripheral

United States, Korea, Republic of, Spain, Italy, United Kingdom, China, Switzerland, Israel, France, Argentina, Brazil, Chile, Slovakia, Uruguay
Gruppo Italiano Multiregionale per lo studio dei...
University of Turin, Italy; Fondazione Italiana Linfomi ONLUS; Centro di Riferimento...

Completed

Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent Lymphoma (LYM-2023)

Lymphoma | Non-Hodgkin Lymphoma

Italy
Fondazione IRCCS Istituto Nazionale dei Tumori,...
Federico II University; IRCCS Cancer Referral Center of Basilicata; European... and other collaborators

Completed

Trial of Diet, Physical Activity and Breast Cancer Recurrences: the DIANA-5 Study (DIANA-5)

Breast Cancer Invasive
IRCCS Centro San Giovanni di Dio Fatebenefratelli
Fondazione Regionale per la Ricerca Biomedica (FRRB); IRCCS Fondazione Istituto... and other collaborators

Recruiting

A Multimodal Approach for Clinical Diagnosis and Treatment of Primary Progressive Aphasia, MAINSTREAM ID:3430931 (MAINSTREAM)

Primary Progressive Aphasia

Italy
Istituto per la Ricerca e l'Innovazione Biomedica
IRCCS Centro Neurolesi "Bonino-Pulejo"; Fondazione Don Carlo Gnocchi Onlus; Istituto... and other collaborators

Recruiting

Modeling Outcome in Patients With Acquired Brain Injuries (MOF-ABI)

Brain Injuries

Italy

Clinical Trials Sponsored by Centro per la Lotta contro l'Infarto - Fondazione Onlus

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Ukraine

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations